FROM:
Alternative Medicine Review 1999 (Jun); 4 (3): 190–192 ~ FULL TEXT
Description and Constituents
Hypericum perforatum (St. John's wort) is a five-petalled,
yellow-flowered perennial weed common to the United States, Europe, and
Asia. Small, dark red dots on the petals contain hypericin, one of many
compounds found in this plant.
Hypericum contains numerous biologically active constituents,
including hypericin and its derivatives, hyperforin, flavonoids (hyperoside,
rutin, quercetin, etc.), catechin, epicatechin, procyanidin B2, amino acid
derivatives (melatonin, GABA), and essential oils.
While it is not yet known definitively which constituent
or constituents are responsible for Hypericum's anti-depressant effects,
recent studies seem to indicate the compound hyperforin is at least in
part responsible. Researchers found the concentration of this compound
to significantly contribute, in a dose-dependent manner, to the anti-depressant
effect of St. John's wort. [1]
Another study, utilizing two behavioral assessments typically used to assess
anti-depressant effects, found a positive correlation between hyperforin
concentration and anti-depressant efficacy. The concentration of other
constituents of several hypericum extracts were not found to be connected
to their efficacy. [2]
Mechanisms of Action
There are a number of proposed mechanisms of action for
Hypericum's anti-depressant effect. It appears it may exert its effectiveness
via several mechanisms involving a number of neurotransmitters and hormones.
Initially, inhibition of monoamine oxidase (MAO) was believed to be the
primary mode of action. More recent research indicates constituents of
St. John's wort exert MAO inhibition only at concentrations higher than
those typically found in commercially available extracts. [3, 4]
Other researchers have found, in animal models, that Hypericum
decreases serotonin re-uptake. [5]
This is the mechanism of many commonly-used anti-depressants, such as Prozac.
Further research found a decrease in post-synaptic receptors in the presence
of Hypericum, resulting in a decrease in serotonin reuptake. [6]
Other researchers have found extracts of St. John's wort
to be potent inhibitors of serotonin, dopamine, norepinephrine, GABA, and
L-glutamate reuptake. [2]
Clinical Applications
Mild to moderate depression: A meta-analysis of
23 studies involving over 1,500 individuals found significantly positive
responses to St. John's wort based on analysis of the Hamilton Depression
Scale before and after treatment. [7]
In a double-blind, placebo-controlled trial, 105 mildly depressed subjects
were given a standardized extract of St. John's wort at a dose of 300 mg
three times daily. [8]
Significant improvements, using the Hamilton Depression Scale, were noted
in depressive mood, sleep, and anxiety.
Severe depression: A randomized, placebo-controlled,
crossover study of 72 patients with major depression found significant
improvement in depression within the first two weeks of the trial in patients
taking 300 mg three times daily of a standardized Hypericum extract. [9]
Hypericum compared to standard anti-depressants:
A study compared 600 mg tid Hypericum standardized extract with imipramine
50 mg tid in 209 severely depressed patients. [10]
The results were similarly positive in both groups, although the Hypericum
group experience significantly fewer side-effects (34.6% compared to 81.4%
in the imipramine group). Hypericum also compares favorably to maprotiline [11]
and amitriptyline. [12]
Seasonal affective disorder (SAD): Twenty patients
suffering from SAD were given either 300 mg tid standardized hypericum
extract along with bright light or the same dose Hypericum with dim light
(apparently not enough to affect SAD). Both groups experienced a significant
reduction in Hamilton Depression Scale scores, with no difference between
the bright and dim light groups. [13]
Antiviral effects: Although extracts of Hypericum,
particularly hypericin, have been found to have in vitro antiviral effects
against HIV, HSV and other viruses, [14–16]
this antiviral activity may not occur in vivo, as some research indicates
hypericin's antiviral effects are dependent on exposure to light, which
may not occur in the body. [17]
However, a small pilot study confirms potential benefit of Hypericum in
vivo. Eighteen people with HIV/AIDS were treated intravenously with a Hypericum
preparation twice weekly in addition to oral doses (undisclosed dosage)
of Hypericum. Sixteen of 18 showed stable or increased CD4 values over
a 40-month period. Improvement in CD4/CD8 ratios were observed in the majority
of subjects. In addition, only two of the 16 positive responders experienced
an opportunistic infection during the 40-month observation period. [18]
Wound healing: Hypericum has long been used both
orally and topically for healing of wounds and burns, due in part to its
antimicrobial effects. In a study of second and third degree burns, burns
treated with a topical Hypericum ointment healed at least three times faster
and keloid formation was prevented when compared to burns treated with
conventional methods. [19]
In another study, a tincture of Hypericum was compared to a topical application
of Calendula. The wound healing effect of oral Hypericum was more pronounced
than the effect of topical Calendula for the healing of incision, excision,
and dead space wounds. [20]